DOR BioPharma, Inc. Employee Directory
Biotechnology ResearchNew Jersey, United States11-50 Employees
DOR BioPharma, Inc. is a biotechnology research company based in Princeton, New Jersey. It develops therapies to address life-threatening side effects of cancer therapies and serious gastrointestinal diseases, and it also works on vaccines for certain bioterrorism agents. Its lead product, orBec, is an oral corticosteroid being developed for acute GI graft-versus-host disease, a potentially fatal complication that can occur after allogeneic hematopoietic cell transplantation. The company’s customers are clinicians and healthcare systems treating patients with GI GVHD and related conditions, with particular relevance to those undergoing transplantation. In addition, its biodefense vaccine program targets specific bioterrorism agents, reflecting a public health and security dimension within the biotechnology research field.